Muehlmann M, Steffinger D, Peraud A, Lehner M, Heinen F, Alperin N, Ertl-Wagner B, Koerte I K
Institut für Klinische Radiologie, Ludwig-Maximilians-Universität München, München, Deutschland.
Radiologe. 2012 Sep;52(9):827-32. doi: 10.1007/s00117-012-2326-z.
CLINICAL/METHODICAL ISSUE: The intracranial pressure (ICP) is a crucially important parameter for diagnostic and therapeutic decision-making in patients with hydrocephalus.
So far there is no standard method to non-invasively assess the ICP. Various approaches to obtain the ICP semi-invasively or non-invasively are discussed and the clinical application of a magnetic resonance imaging (MRI)-based method to estimate ICP (MR-ICP) is demonstrated in a group of pediatric patients with hydrocephalus.
Arterial inflow, venous drainage and craniospinal cerebrospinal fluid (CSF) flow were quantified using phase-contrast imaging to derive the MR-ICP.
A total of 15 patients with hydrocephalus (n=9 treated with shunt placement or ventriculostomy) underwent MRI on a 3 T scanner applying retrospectively-gated cine phase contrast sequences. Of the patients six had clinical symptoms indicating increased ICP (age 2.5-14.61 years, mean 7.4 years) and nine patients had no clinical signs of elevated ICP (age 2.1-15.9 years; mean 9.8 years; all treated with shunt or ventriculostomy). Median MR-ICP in symptomatic patients was 24.5 mmHg (25th percentile 20.4 mmHg; 75th percentile 44.6 mmHg). Median MR-ICP in patients without acute signs of increased ICP was 9.8 mmHg (25th percentile 8.6 mmHg; 75th percentile 11.4 mmHg). Group differences were significant (p < 0.001; Mann-Whitney U-test).
The MR-ICP technique is a promising non-invasive tool for estimating ICP.
Further studies in larger patient cohorts are warranted to investigate its application in children with hydrocephalus.
临床/方法学问题:颅内压(ICP)是脑积水患者诊断和治疗决策的关键重要参数。
目前尚无无创评估颅内压的标准方法。讨论了多种半侵入性或非侵入性获取颅内压的方法,并在一组小儿脑积水患者中展示了基于磁共振成像(MRI)的颅内压估计方法(MR-ICP)的临床应用。
使用相位对比成像对动脉流入、静脉引流和颅脊髓脑脊液(CSF)流动进行量化,以得出MR-ICP。
共有15例脑积水患者(n = 9例接受分流置管或脑室造瘘术治疗)在3T扫描仪上进行MRI检查,应用回顾性门控电影相位对比序列。其中6例患者有提示颅内压升高的临床症状(年龄2.5 - 14.61岁,平均7.4岁),9例患者无颅内压升高的临床体征(年龄2.1 - 15.9岁;平均9.8岁;均接受分流或脑室造瘘术治疗)。有症状患者的MR-ICP中位数为24.5 mmHg(第25百分位数为20.4 mmHg;第75百分位数为44.6 mmHg)。无颅内压急性升高体征患者的MR-ICP中位数为9.8 mmHg(第25百分位数为8.6 mmHg;第75百分位数为11.4 mmHg)。组间差异显著(p < 0.001;曼-惠特尼U检验)。
MR-ICP技术是一种有前景的无创颅内压估计工具。
有必要在更大规模的患者队列中进行进一步研究,以探讨其在小儿脑积水患者中的应用。